Profil
Racheli Ofir is currently the Co-Chief Executive and Chief Technology Officer at Betalin Therapeutics Ltd. Prior to this, she worked at Pluri, Inc. as the Vice President of Data and Intellectual Property from 2007 to 2022.
She holds a doctorate degree from both Technion-Israel Institute of Technology and Israel Institute of Technology.
Aktive Positionen von Racheli Ofir
| Unternehmen | Position | Beginn |
|---|---|---|
Betalin Therapeutics Ltd.
Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Develops micro-pancreas and cell technology | Vorstandsvorsitzender | 01.12.2022 |
Ehemalige bekannte Positionen von Racheli Ofir
| Unternehmen | Position | Ende |
|---|---|---|
| PLURI INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2022 |
Ausbildung von Racheli Ofir
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Pluri, Inc.
Pluri, Inc. BiotechnologyHealth Technology Develops placenta-based cell therapy products for the treatment of muscle trauma and hematological disorders, radiation damage and inflammation | Health Technology |
Technion-Israel Institute of Technology
Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Israel Institute of Technology
Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Betalin Therapeutics Ltd.
Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Develops micro-pancreas and cell technology | Technology Services |
















